PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
The Editors Corner

Professor Raul Santos (University of São Paulo, Brazil) discusses PCSK9 inhibition and lower extremity peripheral arterial disease.
Typically undertreated, what do the new findings from FOURIER mean for these very high risk patients?
Professor François Mach (Geneva University Hospitals, Switzerland) discusses PCSK9 inhibition and cognitive function.
What do the latest publications add to the evidence?
Professor Raul Santos Francoise Mach
Read the report » Read the report »

Read related reports from the American Heart Association Scientific Sessions 2017 here »
Plus the Latest News from the Literature
Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Our popular therapeutic guide

Read online & download second edition now »

Register now at www.pcsk9forum.org to receive the updated third edition e-book with post ACC17 content including the FOURIER trial.
New eBook
Questions & Answers

Why are new treatments needed?

Read the full answer and other questions on the PCSK9 Forum »
Educational Partners
and Supporters
Amgen The Medicines Company pFizer Sanofi
Copyright PCSK9 Forum 2017. Please click here to unsubscribe from future mailings.